Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-15
DOI
10.1038/s41598-017-16112-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration
- (2016) Jiaxiu Xiong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
- (2016) Zhongxing Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The highly expressed 5’isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration
- (2016) Omar Salem et al. BMC GENOMICS
- Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
- (2016) Sumaira Amir et al. BRITISH JOURNAL OF CANCER
- miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway
- (2016) Ravand Samaeekia et al. CLINICAL CANCER RESEARCH
- Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1
- (2016) Valentina Damiano et al. GENES CHROMOSOMES & CANCER
- Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer
- (2016) WENTONG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer
- (2016) Chia-Wei Chang et al. Oncotarget
- MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells
- (2016) Kai Yin et al. Oncotarget
- Identification and Construction of Combinatory Cancer Hallmark–Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer
- (2016) Shanwu Gao et al. JAMA Oncology
- Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer
- (2015) Ramkishore Gernapudi et al. BREAST CANCER RESEARCH AND TREATMENT
- FOXP3 Controls an miR-146/NF- B Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells
- (2015) R. Liu et al. CANCER RESEARCH
- MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells
- (2015) Suhail Ahmed Kabeer Rasheed et al. Molecular Cancer
- MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer
- (2015) Kirti Shukla et al. Molecular Oncology
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes
- (2015) R Perdigão-Henriques et al. ONCOGENE
- Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data
- (2015) Edwin Wang et al. SEMINARS IN CANCER BIOLOGY
- miR-200c inhibits breast cancer proliferation by targeting KRAS
- (2015) Cailu Song et al. Oncotarget
- miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2
- (2014) Jing Fu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines
- (2014) G Xie et al. BRITISH JOURNAL OF CANCER
- Epithelial–mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
- (2014) Maria Koutsaki et al. CANCER LETTERS
- MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer
- (2014) Wen-Dong Bai et al. INTERNATIONAL JOURNAL OF CANCER
- miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer
- (2014) Jun Wang et al. Molecular Oncology
- STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF- B to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
- (2014) M. Xiang et al. Science Signaling
- miRNA Dysregulation in Breast Cancer
- (2013) L. Mulrane et al. CANCER RESEARCH
- MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)
- (2013) Cindy Körner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting long non-coding RNA to therapeutically upregulate gene expression
- (2013) Claes Wahlestedt NATURE REVIEWS DRUG DISCOVERY
- Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
- (2013) S S Roy et al. ONCOGENE
- MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin
- (2013) N Zhang et al. ONCOGENE
- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer
- (2013) Q Li et al. ONCOGENE
- Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets
- (2013) Naif Zaman et al. Cell Reports
- MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
- (2012) Jessica Bockhorn et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
- (2012) Chun-Wen Cheng et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer
- (2012) Katarzyna Augoff et al. Molecular Cancer
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer
- (2011) K. J. Png et al. GENES & DEVELOPMENT
- MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development
- (2011) Holger Heyn et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer
- (2011) Regalla Kumarswamy et al. INTERNATIONAL JOURNAL OF CANCER
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
- (2011) Ni Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Aryl Hydrocarbon Receptor Agonists Induce MicroRNA-335 Expression and Inhibit Lung Metastasis of Estrogen Receptor Negative Breast Cancer Cells
- (2011) S. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer
- (2010) F. Germán Rodríguez-González et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-31: A crucial overseer of tumor metastasis and other emerging roles
- (2010) Scott Valastyan et al. CELL CYCLE
- WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade
- (2010) Khalid Sossey-Alaoui et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
- (2010) Jun Yu et al. Molecular Cancer
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
- Identification of high-quality cancer prognostic markers and metastasis network modules
- (2010) Jie Li et al. Nature Communications
- Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer Metastasis
- (2009) Douglas R. Hurst et al. CANCER RESEARCH
- Long noncoding RNAs: functional surprises from the RNA world
- (2009) J. E. Wilusz et al. GENES & DEVELOPMENT
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- The cell growth suppressor, mir-126, targets IRS-1
- (2008) Jin Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-206 Expression Is Down-regulated in Estrogen Receptor -Positive Human Breast Cancer
- (2008) N. Kondo et al. CANCER RESEARCH
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
- Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
- (2008) D Bhaumik et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started